Reuters logo
BRIEF-Emergent Biosolutions receives FDA approval to manufacture ACAM2000 at Massachusetts facility
November 20, 2017 / 12:15 PM / a month ago

BRIEF-Emergent Biosolutions receives FDA approval to manufacture ACAM2000 at Massachusetts facility

Nov 20 (Reuters) - Emergent Biosolutions Inc

* Emergent Biosolutions receives FDA approval to manufacture ACAM2000 at Canton, Massachusetts facility

* Emergent Biosolutions says it expects to complete all remaining product deliveries under existing CDC contract in early 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below